SI9520077A - Sterolni derivati uporabljeni za regulacijo mejoze - Google Patents

Sterolni derivati uporabljeni za regulacijo mejoze Download PDF

Info

Publication number
SI9520077A
SI9520077A SI9520077A SI9520077A SI9520077A SI 9520077 A SI9520077 A SI 9520077A SI 9520077 A SI9520077 A SI 9520077A SI 9520077 A SI9520077 A SI 9520077A SI 9520077 A SI9520077 A SI 9520077A
Authority
SI
Slovenia
Prior art keywords
compound according
carbon atoms
group
compound
hydrogen
Prior art date
Application number
SI9520077A
Other languages
English (en)
Slovenian (sl)
Inventor
Anne Grete Byskov
Claus Yding Andersen
Lars Nordholm
Ole Wassmann
Ivan Verner Diers
Erling Guddal
Henning Thoegersen
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of SI9520077A publication Critical patent/SI9520077A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/001—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class spiro-linked
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
SI9520077A 1994-06-23 1995-06-23 Sterolni derivati uporabljeni za regulacijo mejoze SI9520077A (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK75394 1994-06-23
DK24195 1995-03-09
PCT/DK1995/000265 WO1996000235A1 (en) 1994-06-23 1995-06-23 Sterol derivatives used for regulation of meiosis

Publications (1)

Publication Number Publication Date
SI9520077A true SI9520077A (sl) 1998-06-30

Family

ID=26063596

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9520077A SI9520077A (sl) 1994-06-23 1995-06-23 Sterolni derivati uporabljeni za regulacijo mejoze

Country Status (26)

Country Link
US (1) US5716777A (ja)
EP (1) EP0767798B1 (ja)
JP (1) JP3987105B2 (ja)
KR (1) KR100408369B1 (ja)
CN (1) CN1068333C (ja)
AT (1) ATE248852T1 (ja)
AU (1) AU694240B2 (ja)
BG (1) BG101067A (ja)
BR (1) BR9508074A (ja)
CA (1) CA2192941C (ja)
CZ (1) CZ289407B6 (ja)
DE (1) DE69531682T2 (ja)
DK (1) DK0767798T3 (ja)
ES (1) ES2204955T3 (ja)
FI (1) FI117159B (ja)
HU (1) HUT76343A (ja)
IL (1) IL114294A (ja)
IS (1) IS4404A (ja)
MX (1) MX9700174A (ja)
NO (1) NO314534B1 (ja)
PL (1) PL186688B1 (ja)
RU (1) RU2194510C2 (ja)
SI (1) SI9520077A (ja)
SK (1) SK165596A3 (ja)
UA (1) UA51622C2 (ja)
WO (1) WO1996000235A1 (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ279797A3 (cs) * 1995-03-06 1998-01-14 Novo Nordisk A/S Způsob stimulace miózy zárodečné buňky a použití sloučeniny, která způsobuje akumulaci látky aktivující endogenní miózu
BR9608968A (pt) * 1995-06-23 1999-06-29 Novo Nordisk As Composto e processo para regular meiose em uma célula germinativa de mamífero
US6645953B2 (en) * 1995-06-23 2003-11-11 Novo Nordisk A/S Meiosis regulating compounds
AU6122696A (en) * 1995-06-23 1997-01-22 Novo Nordisk A/S Meiosis regulating compounds
JP2001506656A (ja) 1996-12-20 2001-05-22 ノボ ノルディスク アクティーゼルスカブ 減数分裂調節化合物
CN1260802A (zh) * 1997-05-16 2000-07-19 阿克佐诺贝尔公司 20－芳烷基－5α－孕甾烷衍生物
CA2289524A1 (en) * 1997-06-04 1998-12-10 Akzo Nobel Nv 17.beta.-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
DK1042353T3 (da) 1997-12-18 2002-11-04 Akzo Nobel Nv 17-beta-aryl(arylmethyl)oxy(thio)alkylandrostanderivater
CA2331962A1 (en) * 1998-05-13 1999-11-18 Novo Nordisk A/S Meiosis regulating compounds
IL139241A0 (en) * 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
JP2002516272A (ja) * 1998-05-26 2002-06-04 シエーリング アクチエンゲゼルシヤフト ｃＡＭＰを増大させる化合物を単独でまたは減数分裂を刺激する少なくとも１つの化合物との組合せ物での不妊治療
IL140216A0 (en) * 1998-06-19 2002-02-10 Novo Nordisk As Meiosis regulating compounds
EP1137660B1 (en) * 1998-12-11 2002-10-02 Akzo Nobel N.V. 22s-hydroxycholesta-8,14-diene derivatives with meiosis regulating activity
WO2000036132A1 (en) 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
BR0008065A (pt) * 1999-02-10 2001-11-06 Schering Aktiengellschaft Derivados de colestano insaturados e seu uso para a preparação de medicamentos que regulam meiose
EP1156822B1 (en) * 1999-02-24 2006-02-08 Novo Nordisk A/S Iin vitro method for synchronisation of oocyte maturation
EP1156821B1 (en) * 1999-02-24 2007-05-02 Novo Nordisk A/S Treatment of infertility
CN1341147A (zh) * 1999-02-26 2002-03-20 诺沃挪第克公司 减数分裂活化甾醇增大着床率
AU3285000A (en) * 1999-03-09 2000-09-28 Akzo Nobel N.V. 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
IL148234A0 (en) * 1999-09-16 2002-09-12 Novo Nordisk As Composition for ivf
EP1127890A1 (en) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid derivatives with an additional ring annulated to ring A and use of these derivatives for the preparation of meiosis regulating medicaments
AU3376501A (en) * 2000-02-25 2001-09-03 Novo Nordisk A/S Improvement of implantation rate
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
WO2001088098A2 (en) * 2000-05-18 2001-11-22 Schering Aktiengesellschaft Fertilization of aged oocytes
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
AU2003203145A1 (en) * 2002-02-22 2003-09-09 Novo Nordisk A/S A transducer of mas signalling
WO2012044817A2 (en) * 2010-10-01 2012-04-05 Indiana University Research And Technology Corporation Process for preparing delta-7,9(11) steroids from ganoderma lucidum and analogs thereof
US9165822B2 (en) 2013-03-11 2015-10-20 Taiwan Semiconductor Manufacturing Company, Ltd. Semiconductor devices and methods of forming same
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ

Also Published As

Publication number Publication date
PL317830A1 (en) 1997-04-28
DE69531682T2 (de) 2004-07-15
FI965144A (fi) 1997-02-20
IL114294A (en) 2002-09-12
DE69531682D1 (de) 2003-10-09
ATE248852T1 (de) 2003-09-15
RU2194510C2 (ru) 2002-12-20
IS4404A (is) 1996-12-23
CZ372596A3 (en) 1997-07-16
CA2192941C (en) 2009-04-14
AU694240B2 (en) 1998-07-16
CA2192941A1 (en) 1996-01-04
BG101067A (en) 1997-08-29
BR9508074A (pt) 1997-08-12
CN1151164A (zh) 1997-06-04
JP3987105B2 (ja) 2007-10-03
EP0767798A1 (en) 1997-04-16
MX9700174A (es) 1997-04-30
CZ289407B6 (cs) 2002-01-16
HUT76343A (en) 1997-08-28
UA51622C2 (uk) 2002-12-16
AU2734395A (en) 1996-01-19
NO965516D0 (no) 1996-12-20
KR100408369B1 (ko) 2004-04-28
DK0767798T3 (da) 2003-12-22
JPH10502060A (ja) 1998-02-24
IL114294A0 (en) 1995-10-31
WO1996000235A1 (en) 1996-01-04
SK165596A3 (en) 1997-08-06
HU9603584D0 (en) 1997-02-28
ES2204955T3 (es) 2004-05-01
NO314534B1 (no) 2003-04-07
PL186688B1 (pl) 2004-02-27
FI117159B (fi) 2006-07-14
FI965144A0 (fi) 1996-12-20
CN1068333C (zh) 2001-07-11
NO965516L (no) 1997-02-21
EP0767798B1 (en) 2003-09-03
US5716777A (en) 1998-02-10

Similar Documents

Publication Publication Date Title
RU2194510C2 (ru) Применение соединений стерина для получения лекарственного средства, регулирующего мейоз, и способ регуляции мейоза
EP0857173B1 (en) Meiosis regulating compounds
EP0946584B1 (en) Meiosis regulating compounds
DE69913513T2 (de) Verwendung von verbindungen mit der fähigkeit die meiose zu regulieren
US20030004148A1 (en) Regulation of meiosis
RU2289587C2 (ru) Стероидные соединения, способы их получения, фармацевтическая композиция, способы регуляции и совершенствования воспроизведения, промежуточные соединения
KR20020013541A (ko) 14β-Ｈ-스테롤, 그를 포함하는 제약 조성물, 및 감수분열조절 약제 제조에 있어서 그의 유도체의 용도
DE69903346T2 (de) 22s-hydroxycholesta-8,14-dien derivate mit meiose regulierende aktivität
DE602004013453T2 (de) Thiomorpholinosteroidverbindungen, deren verwendung zur herstellung von die meiose steuernden medikamenten und verfahren zu deren herstellung
KR20010101820A (ko) 불포화 콜레스탄 유도체 및 감수분열 조절 약제 제조에있어서 그의 용도
CZ291308B6 (cs) Sterolové deriváty regulující meiózu a způsob regulace
MXPA98000123A (en) Compounds that regulate the meio